Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10961896 | Journal of Veterinary Cardiology | 2015 | 13 Pages |
Abstract
Cardiac biomarkers have been used in cats as part of the clinical assessment of heart disease for over a decade. They are widely available to practitioners through commercial reference laboratories. The evidence base for the use of cardiac biomarkers (primarily N-terminal pro-B type natriuretic peptide and cardiac troponin I) in cats is comprehensively reviewed in this article, focusing on each of six specific areas: distinguishing cardiac from non-cardiac causes of respiratory distress; measurement of cardiac biomarkers in urine and pleural fluid; identification of occult cardiomyopathy; effects of systemic disease on circulating concentrations of cardiac biomarkers; point-of-care biomarker testing, and the possible prognostic utility of cardiac biomarker measurement.
Related Topics
Life Sciences
Agricultural and Biological Sciences
Animal Science and Zoology
Authors
K. BSc, BVSc, MVetMed, D.J. BSc, BVetMed, PhD, V. MA, VetMB, PhD,